Adipose tissue dysfunction as determinant of obesity-associated metabolic complications

M Longo, F Zatterale, J Naderi, L Parrillo… - International journal of …, 2019 - mdpi.com
Obesity is a critical risk factor for the development of type 2 diabetes (T2D), and its
prevalence is rising worldwide. White adipose tissue (WAT) has a crucial role in regulating …

NAFLD in children: new genes, new diagnostic modalities and new drugs

V Nobili, A Alisi, L Valenti, L Miele… - Nature reviews …, 2019 - nature.com
Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in children and adolescents. Over the past 5 years, developments have …

Added sugars and cardiovascular disease risk in children: a scientific statement from the American Heart Association

MB Vos, JL Kaar, JA Welsh, LV Van Horn, DI Feig… - Circulation, 2017 - Am Heart Assoc
Background: Poor lifestyle behaviors are leading causes of preventable diseases globally.
Added sugars contribute to a diet that is energy dense but nutrient poor and increase risk of …

Machine learning techniques for prediction of early childhood obesity

TM Dugan, S Mukhopadhyay, A Carroll… - Applied clinical …, 2015 - thieme-connect.com
Objectives: This paper aims to predict childhood obesity after age two, using only data
collected prior to the second birthday by a clinical decision support system called CHICA …

[PDF][PDF] Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic

I Doycheva, KD Watt, N Alkhouri - Hepatology, 2017 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a significant health burden in adolescents and
young adults (AYAs) which has substantially risen in prevalence over the last decades. The …

[HTML][HTML] The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

E Jennison, CD Byrne - Clinical and molecular hepatology, 2021 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease, with
a prevalence that is increasing in parallel with the global rise in obesity and type 2 diabetes …

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies

M Maestri, F Santopaolo, M Pompili, A Gasbarrini… - Frontiers in …, 2023 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is frequently associated with metabolic disorders,
being highly prevalent in obese and diabetic patients. Many concomitant factors that …

Association between dietary fiber intake and non-alcoholic fatty liver disease in adults

H Zhao, A Yang, L Mao, Y Quan, J Cui, Y Sun - Frontiers in Nutrition, 2020 - frontiersin.org
Background: Evidence on the association of non-alcoholic fatty liver disease (NAFLD), a
public health concern, with dietary fiber intake is inconsistent. Objective: To investigate the …

Non-alcoholic fatty liver disease in obese youth with insulin resistance and type 2 diabetes

S Scapaticci, E D'Adamo, A Mohn, F Chiarelli… - Frontiers in …, 2021 - frontiersin.org
Currently, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic
liver disease in children and adolescents worldwide. Simultaneously to the epidemic …

Consumption of sugar-sweetened beverages has a dose-dependent effect on the risk of non-alcoholic fatty liver disease: an updated systematic review and dose …

H Chen, J Wang, Z Li, CWK Lam, Y Xiao, Q Wu… - International journal of …, 2019 - mdpi.com
Background: Non-alcoholic fatty liver disease (NAFLD) is a serious health problem, but the
dose-response relationship between sugar-sweetened beverages (SSBs) and NAFLD …